155 results
Page 4 of 8
8-K
EX-99.1
ijngh
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
8-K
EX-10.3
axfvzoj8do lvv881j
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-99.1
hja37j17eun6tvhpomup
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
9y7usfh7
11 Sep 20
Departure of Directors or Certain Officers
4:17pm
424B3
ek6e7 tunn1bu6
28 Aug 20
Prospectus supplement
4:31pm
8-K
EX-99.1
40o atxvzib
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
425
v6ulg1qmw5s95 rvl
24 Jun 20
Business combination disclosure
5:11pm
8-K
od1loh87 d54
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
425
hehobej 8xosk1bmmn
24 Jun 20
Business combination disclosure
4:03pm
425
3al5tdu
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.3
3pz9kv8x
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.4
j9i65vt
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.2
khiht pg7h
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
bh2xzw862sksrwsp75
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm